Basic Information
Basic information for TRAM2-AS1-210-45aa
Peptide Name TRAM2-AS1-210-45aa
Genome Position chr6:52583206-52583340[+]
Species Human
Peptide Sequence MENVCGAGTRSVYARIFFQCVSPVIFLSLYLTRYVARLPKTSLAF
Peptide Length 45
Unique No (TRAM2-AS1-202-45aa,TRAM2-AS1-203-45aa,TRAM2-AS1-204-45aa,TRAM2-AS1-208-45aa,TRAM2-AS1-211-45aa,TRAM2-AS1-212-45aa,TRAM2-AS1-213-45aa,TRAM2-AS1-214-45aa,TRAM2-AS1-215-45aa)
Grand Average of Hydropathicity 0.6378
Relative Molecular Mass 5882.79
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000225791;TRAM2-AS1
Transcript ID/Name ENST00000663931;TRAM2-AS1-210
Transcript Length 2744
Coding Ability 0.4417
DNA Sequence Corresponding to Peptide ATGGAGAATGTATGTGGAGCAGGCACCCGGAGTGTCTATGCCAGGATTTTTTTTCAGTGCGTTTCACCGGTTATATTTTTGTCTCTTTACCTTACAAGATATGTGGCACGTTTGCCTAAAACAAGCCTTGCTTTC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :